21 May 2013
Keywords: fda, committee, gives, nod, glaxo, otc, zantac
Article | 24 July 1995
A US Food and Drug Administration advisory committee has recommended
approval for an over-the-counter version of Glaxo's antiulcerant Zantac
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 July 1995
17 July 1995
20 May 2013
© 2013 thepharmaletter.com